GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (NYSE:TARO) » Definitions » Days Payable

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Days Payable : 55.65 (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is Taro Pharmaceutical Industries Days Payable?

Taro Pharmaceutical Industries's average Accounts Payable for the three months ended in Dec. 2023 was $47.1 Mil. Taro Pharmaceutical Industries's Cost of Goods Sold for the three months ended in Dec. 2023 was $77.3 Mil. Hence, Taro Pharmaceutical Industries's Days Payable for the three months ended in Dec. 2023 was 55.65.

The historical rank and industry rank for Taro Pharmaceutical Industries's Days Payable or its related term are showing as below:

TARO' s Days Payable Range Over the Past 10 Years
Min: 30.91   Med: 44.25   Max: 88.04
Current: 63.82

During the past 13 years, Taro Pharmaceutical Industries's highest Days Payable was 88.04. The lowest was 30.91. And the median was 44.25.

TARO's Days Payable is ranked worse than
64.28% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.82 vs TARO: 63.82

Taro Pharmaceutical Industries's Days Payable declined from Dec. 2022 (74.50) to Dec. 2023 (55.65). It may suggest that Taro Pharmaceutical Industries accelerated paying its suppliers.


Taro Pharmaceutical Industries Days Payable Historical Data

The historical data trend for Taro Pharmaceutical Industries's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Days Payable Chart

Taro Pharmaceutical Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.46 47.60 65.11 88.04 81.91

Taro Pharmaceutical Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.50 88.17 61.53 62.64 55.65

Competitive Comparison of Taro Pharmaceutical Industries's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taro Pharmaceutical Industries's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Days Payable distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's Days Payable falls into.



Taro Pharmaceutical Industries Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Taro Pharmaceutical Industries's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

Days Payable (A: Mar. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2022 ) + Accounts Payable (A: Mar. 2023 )) / count ) / Cost of Goods Sold (A: Mar. 2023 )*Days in Period
=( (68.232 + 68.484) / 2 ) / 304.629*365
=68.358 / 304.629*365
=81.91

Taro Pharmaceutical Industries's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (43.059 + 51.183) / 2 ) / 77.264*365 / 4
=47.121 / 77.264*365 / 4
=55.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Taro Pharmaceutical Industries Days Payable Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Executives
Sun Pharma Global Inc 10 percent owner
Sun Pharmaceutical Industries Ltd 10 percent owner, other: Affiliated Party 17/B, MAHAL INDUSTRIAL ESTATE, MAHAKALI CAVES ROAD, ANDEHERI (EAST) K7 400 093
Alkaloida Chemical Co Exclusive Group Ltd. 10 percent owner KABAY JANOS UT 29., TISZAVASVARI K5 4440
Franklin Resources Inc 10 percent owner FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403

Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Headlines

From GuruFocus

Taro to Announce Second Quarter Results on October 28, 2021

By Business Wire Business Wire 10-21-2021

Taro Announces Resignation of Chief Financial Officer

By Business Wire Business Wire 07-14-2021

Taro to Announce Third Quarter Results on January 27, 2021

By Business Wire Business Wire 01-21-2021

Taro Appoints New Chief Financial Officer

By Business Wire Business Wire 12-01-2021

Taro Launches Specialty Generic Deferiprone Tablets, 500mg in the U.S.

By Business Wire Business Wire 09-28-2020

Taro to Release Third Quarter Results on January 24, 2023

By Business Wire Business Wire 01-19-2023

Taro to Announce First Quarter Results on July 27, 2021

By Business Wire Business Wire 07-21-2021